SCHEMBL30775341

SCHEMBL30775341

NC(=O)CN1CCC(N2CCOCC2)CC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.67
ALDH1A1 P00352 1/20 0.55
L3MBTL3 Q96JM7 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HTR7 P34969 1/20 0.43
HSD17B10 Q99714 2/20 0.43
ITGB3 P05106 1/20 0.43
ITGA2B P08514 1/20 0.43
ALOX15 P16050 2/20 0.42
TSHR P16473 2/20 0.42
HRH3 Q9Y5N1 2/20 0.41
CBX7 O95931 1/20 0.40
CDYL2 Q8N8U2 1/20 0.40
CDYL Q9Y232 1/20 0.40
CDY1; CDY1B Q9Y6F8 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
AOC3 Q16853 2/20 0.39
POLB P06746 1/20 0.39
PKM P14618 1/20 0.39
ACHE P22303 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5969639 0.84 HSD17B10 (0.63) KDM4EALDH1A1L3MBTL3L3MBTL1HTR7
SCHEMBL4472836 0.84 KDM4E (0.51) KDM4EALDH1A1L3MBTL3L3MBTL1ITGB3
Hydrochloric Acid SCHEMBL1371748 0.83 HSD17B10 (0.61) KDM4EALDH1A1L3MBTL3L3MBTL1HTR7
SCHEMBL12640337 0.83 KDM4E (0.55) KDM4EALDH1A1L3MBTL3L3MBTL1HTR7
SCHEMBL3064605 0.82 KDM4E (0.54) KDM4EALDH1A1L3MBTL3L3MBTL1ITGB3
SCHEMBL429276 0.81 KDM4E (1.00) KDM4EALDH1A1HSD17B10ALOX15TSHR
SCHEMBL16570813 0.81 KDM4E (1.00) KDM4EALDH1A1HSD17B10ALOX15TSHR
SCHEMBL22266279 0.79 KDM4E (0.43) KDM4EALDH1A1L3MBTL3L3MBTL1ITGB3
SCHEMBL21056402 0.79 KDM4E (0.43) KDM4EALDH1A1L3MBTL3L3MBTL1ITGB3
Hydrochloric Acid SCHEMBL8859868 0.79 KDM4E (0.95) KDM4EALDH1A1HSD17B10ALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240025884-A1 COMPOUNDS AS GCN2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF DONG-A ST CO., LTD. (KR) 2024-01-25 US claimed
US-12240836-B2 Compounds as GCN2 inhibitors, pharmaceutical compositions and uses thereof DONG-A ST CO., LTD. (KR) 2025-03-04 US disclosed
US-20240025884-A1 COMPOUNDS AS GCN2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF DONG-A ST CO., LTD. (KR) 2024-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12240836-B2 Compounds as GCN2 inhibitors, pharmaceutical compositions and uses thereof EIF2AK4, GCN1, GCGR KDM4E 4591/4885ALDH1A1 3927/4885L3MBTL3 4731/4885
US-20240025884-A1 COMPOUNDS AS GCN2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF EIF2AK4, GCN1, GCGR KDM4E 4591/4885ALDH1A1 3927/4885L3MBTL3 4731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.